For the majority of people with the virus in the U.S., dying with HIV has turned into living a long life with HIV.
The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...
The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in the country. This is despite South Africa having the world's biggest ...
Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
Also known as polymorphic eruption of pregnancy (PEP), it is one of the most common types of rash you can get during pregnancy. Though harmless, it does cause an itchy rash with hive-like bumps on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results